Differential effects of dietary canola and soybean oil intake on oxidative stress in stroke-prone spontaneously hypertensive rats by Papazzo, Annateresa et al.
Deakin Research Online 
 
This is the published version:  
 
 
Papazzo, Annateresa, Conlan, Xavier A., Lexis, Louise and Lewandowski, Paul A. 2011, 
Differential effects of dietary canola and soybean oil intake on oxidative stress in stroke-
prone spontaneously hypertensive rats, Lipids in health and diease, vol. 10, no. 98, pp. 1-8. 
 
 








This is an open access article distributed under the terms of the attached BioMed Central 




Copyright : 2011, BioMed Central Ltd. 
RESEARCH Open Access
Differential effects of dietary canola and soybean
oil intake on oxidative stress in stroke-prone
spontaneously hypertensive rats
Annateresa Papazzo1, Xavier A Conlan2, Louise Lexis3 and Paul A Lewandowski1*
Abstract
Background: Canola oil shortens the life span of stroke-prone spontaneously hypertensive (SHRSP) rats compared
with rats fed soybean oil when given as the sole dietary lipid source. One possible mechanism leading to the
damage and deterioration of organs due to canola oil ingestion is oxidative stress. This study investigated the
effect of canola oil intake on oxidative stress in this animal model.
Method: Male SHRSP rats, were fed a defatted control diet containing 10% wt/wt soybean oil or a defatted
treatment diet containing 10% wt/wt canola oil, and given water containing 1% NaCl. Blood pressure was
measured weekly. Blood was collected prior to beginning the diets and at the end of completion of the study for
analysis of red blood cell (RBC) antioxidant enzymes, RBC and plasma malondialdehyde (MDA), plasma 8-
isoprostane and plasma lipids.
Results: Canola oil ingestion significantly decreased the life span of SHRSP rats compared with soybean oil, 85.8 ±
1.1 and 98.3 ± 3.4 days, respectively. Systolic blood pressure increased over time with a significant difference
between the diets at the 6th week of feeding. Canola oil ingestion significantly reduced RBC superoxide dismutase,
glutathione peroxidase and catalase activities, total cholesterol and low-density lipoprotein cholesterol compared
with soybean oil. There were no significant differences in RBC MDA concentration between canola oil fed and
soybean oil fed rats. In contrast, plasma MDA and 8-isoprostane concentration was significantly lower in the canola
oil group compared to the soybean oil group.
Conclusion: In conclusion, canola oil ingestion shortens the life span of SHRSP rats and leads to changes in
oxidative status, despite an improvement in the plasma lipids.
Background
The stroke-prone spontaneously hypertensive (SHRSP)
rat is a model of human essential hypertension and
stroke, and is derived from the spontaneously hyperten-
sive rat (SHR) and the Wistar-Kyoto (WKY) rat strain
[1-4]. In this model, ingestion of canola oil as the sole
dietary fat source (added at 10% wt/wt to standard rat
chow) has been reported to shorten life span compared
to the soybean oil or perilla oil [1,2,5-9]. The sulphur
and fatty acid composition of canola oil does not appear
to cause the shortened life span [8]. Furthermore, the
concentration of phytosterols in canola oil has also been
suggested to be a contributing factor. However, conflict-
ing results have shown no clear correlation between the
content of phytosterols in the diet and tissues and survi-
val time observed [4,7]. Recent studies suggest that one
of the key mechanisms leading to the shortened life
span in SHRSP rats is via the acceleration of hyperten-
sion-related deterioration of organs [6,7]. An increase in
blood pressure [10] and enhanced Na+, K+-ATPase
activities [6] have been reported as a result of canola oil
ingestion, and may promote the deterioration of organs
[6]. Other hypertension-related conditions induced by
canola oil ingestion include tissue lesions in the heart
and kidney [7].
There is growing evidence that oxidative stress leads to
vascular damage and plays a critical role in the pathogen-
esis of cardiovascular diseases such as hypertension [11,12].
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It has been found that production of reactive oxygen spe-
cies (ROS) is increased in both experimental and clinical
hypertension, with a decrease in the antioxidant reserve
in vascular tissues [13,14]. In both experimental and clin-
ical hypertension, ROS and oxidative stress have been
found to be associated with end-stage organ damage [14].
Hypertension is also a risk factor for stroke [15]. It has
been shown that in both ischemic and hemorrhagic
stroke, reactive oxygen species (ROS) production is
increased, and oxidative stress is a key mediator of tissue
damage [15,16].
Cells are protected against ROS by a complex antioxi-
dant system present within the cells, which includes
superoxide dismutase (SOD), catalase and glutathione
peroxidase (GPx) [17]. Within RBCs, protective mechan-
isms exist to detoxify and scavenge ROS, and protect
endothelial cells against free radical damage [18]. There
is an inverse relationship between reduced activities of
antioxidants (SOD, GPx and vitamin E) and increased
lipid peroxidation products in blood and cardiovascular
disease [19]. The activities of the antioxidant enzymes,
SOD, catalase and GPx have been found to be reduced
both in whole blood and peripheral mononuclear cells
in hypertensive subjects [20]. In addition, concentrations
of malondialdehyde (MDA) in whole blood and periph-
eral mononuclear cells have been shown to be increased
in hypertensive subjects compared to control [20]. MDA
is an end product of lipid peroxidation, and therefore
increased concentrations indicate an increase in ROS
concentration and resulting oxidative damage [20]. After
an acute ischemic stroke the activities of SOD and GPx
were reduced and the concentration of MDA was
increased in RBCs of human subjects [21]. This study
aimed to determine if enhanced oxidative stress and
altered antioxidant capacity is associated with canola oil
ingestion in SHRSP rats.
Methods
Animal husbandry and study design
Experimental design was based on previous life span
studies investigating canola oil intake in SHRSP rats [6]
to allow direct comparisons to be made. Thirty-four
male SHRSP rats (Deakin University, Australia) were
used for this study. Ten of the SHRSP rats were sacri-
ficed at 5 weeks of age and blood was collected for ana-
lysis (pre-treatment data). Twenty-four, 4 week old
SHRSP rats were randomly assigned into two groups of
12 animals each, a control and treatment group, and
acclimatized for one week. During acclimatization they
were given a standard pellet diet and water ad libitum
(Specialty Feeds, Western Australia). Following this, the
two groups were fed, respectively, a defatted control diet
containing 10% wt/wt soybean oil or a defatted treat-
ment diet containing 10% wt/wt canola oil (Speciality
Feeds, Western Australia), and life span was determined.
The fatty acid composition and total antioxidant status
of the diets are shown in Table 1. Each group was given
water containing 1% NaCl to accelerate the development
of hypertension. The animals were maintained on a 12
hr light/dark photo-period with a room temperature of
21 ± 2°C. Animal body weights, food intake and water
consumption were determined once a week, while the
health of the animals was monitored daily. When a rat
was found to suffer from stroke, paralysis or to be in
pain they were euthanized via intra-peritoneal injection
with lethabarb (50 mg/kg) and blood was collected for
analysis (post-treatment data). Approval for this project
was granted by the Deakin University Animal Welfare
Committee.
Blood pressure measurement
Blood pressure was measured weekly over the course of
their life span using a tail cuff sphygmomanometer (Biopac
Systems). For each animal systolic blood pressure was
obtained as an average of three readings as each time point.
Blood collection and processing
After the animal was anaesthetised, blood was collected
via cardiac puncture into EDTA coated tubes. Immedi-
ately after blood collection, samples were centrifuged at
600 × g for 10 minutes at 4°C. The plasma was then
removed and stored at -80°C until analysis of plasma
lipids: triglycerides, total cholesterol, high density lipo-
protein cholesterol (HDL-C) and low density lipoprotein
cholesterol (LDL-C), and MDA. RBCs were then washed
3 times by adding an equal volume of 0.9% (w/v) NaCl,
mixed carefully and centrifuged at 600 × g for 10 minutes
Table 1 Fatty acid composition and total antioxidant
status of canola oil and soybean oil diets




14:0 Myristic acid 0.2 0.1
16:0 Palmitic acid 11.0 7.0
16:1 Palmitoleic acid 0.1 0.1
18:0 Stearic acid 4.0 2.0
18:1 Oleic acid 23.0 53.0
18:2 Linoleic acid 48.0 23.0
18:3 Linolenic acid 6.0 10.0
18:4 Stearidonic acid 0 0.5
20:1 Gadoleic acid 0.2 0.1
20:5 EPA 0.2* 0.2*
22:6 DHA 0.5* 0.5*
Total Antioxidant Status (TEAC mmol/
L)
0.67 ± 0.01 0.66 ± 0.01
*Fatty acid source coming from fish meal found within the diet.
Information provided by Speciality Feeds (Western Australia), which produced
both diets.
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at 4°C. The supernatant was removed and discarded. An
equal volume of cold distilled water and RBCs were
mixed well to lyse the cells. The hemolysate was stored at
- 80°C for subsequent analysis of antioxidant enzymes:
SOD, catalase and GPx, and MDA.
Erythrocyte antioxidant enzymes
Superoxide dismutase (SOD) activity was determined
using a commercially available kit (Cayman Chemical
Company) following the manufacturer’s instructions.
This assay utilizes xanthine oxidase and hypoxanthine to
generate superoxide radicals that are detected by tetra-
zolium salt with absorbance read at 540 nm using a
microplate analyser (Fusion-Alpha HT, PerkinElmer).
One unit of SOD is defined as the amount of enzyme
required to inhibit the distmutation of the superoxide
radical by 50%.
Catalase activity was determined using a commercially
available kit (Cayman Chemical Company) following
manufacturer’s instructions. This method is based on
the reaction of methanol with the enzyme in the pre-
sence of an optimal concentration of hydrogen peroxide.
The absorbance was read at 540 nm using a microplate
analyser (Fusion-Alpha HT, PerkinElmer).
GPx activity was determined using a modification of
the method of Wheeler et al. (1990) [22]. This assay is
based on the oxidation of nicotinamide adenine dinu-
cleotide phosphate (NADPH) following the reduction of
t-butyl hydroperoxide. A decrease in absorbance at 340
nm results from oxidation of NADPH to NADP+ and
the rate of this decrease is proportional to the GPx
activity in the sample.
All erythrocyte enzyme activities were normalised to
haemoglobin concentration, which was determined by
adding 20 μl of 200/1 hemolysate and 480 μl of Darb-
kin’s reagent. The sample was left to stand at room tem-
perature for 5 minutes and the absorbance read at 540
nm using a spectrophotometer (Biochrom).
Lipid peroxidation
MDA in plasma and erythrocytes was determined via
high performance liquid chromatography (HPLC)
according to the method by Sim et al. (2003) [23].
Briefly, 100 μl hemolysate or 50 μl plasma samples were
hydrolysed with 1.3 M sodium hydroxide, incubated at
60°C for 60 minutes and cooled on ice for 5 minutes.
To precipitate the proteins, 35% perchloric acid was
added, cooled on ice for 5 minutes and centrifuged at
3500 × g for 10 minutes. The samples were protected
from light from this step onwards. To the supernant 30
μl of 2,3-dinitrophenylhydrazine reagent was added and
incubated for 10 minutes at room temperature. The
aqueous phase was extracted twice with hexane and eva-
porated. The dry extract was reconstituted with 100 μl
mobile phase, and a 45 μl injection volume was used.
MDA concentrations were determined at 310 nm using
HPLC (Agilent Technologies) with an Eclipse XDB-C18
column (150 × 4.6 mm, 5 μm, 1 ml/min flow rate, 9.8
MPa backpressure). External standards (5, 10, 20 and 40
μM) of MDA aliquots of suitable concentrations were
used.
Total 8-isoprostane concentrations were analysed in
plasma using an enzyme immunoassay (EIA) kit (Cay-
man Chemicals) following manufactures instructions.
Prior to analysis plasma samples were hydrolysed by
addition of 25 μl 2 M NaOH to each 100 μl plasma
sample. The samples were incubated at 45°C for 2
hours. Following this, 25 μl 10N HCl acid was added
and the samples were centrifuged for 5 minutes at
12,000 × g. The supernatant was removed and used for
the determination of total 8-isoprostane using the EIA
kit. This assay is based on the competition between 8-
isoprostane and an 8-isoprostane acetycholinesterase
(AChE) conjugate for a limited number of 8-iso-PGF2a-
specific rabbit anti-serum binding sites, values were
expressed as pg/ml of plasma.
Plasma lipids
Plasma triglycerides, total cholesterol and High density
lipoprotein cholesterol (HDL-C) were determined using
commercially available kits (Thermo Electron Corpora-
tion) in a 96 well plate format (Fusion-Alpha HT, Perki-
nElmer), following the manufactures instructions.
Low density lipoprotein cholesterol (LDL-C) was
determined using the Friedewald equation [24]: LDL
cholesterol = Total Cholesterol - HDL cholesterol -
(TG/5).
Statistical analysis
Statistical analysis was performed using the SPSS statis-
tical package (version 17.0, SPSS Inc.) for repeated mea-
sures ANOVA and one-way ANOVA. The results are
represented as mean ± SEM. Comparisons between
groups for animal body weight, food intake and water
intake data were analysed using repeated measures
ANOVA. A post hoc pair-wise comparison was also car-
ried out. Statistical analysis of the survival time data was
performed by Log-Rank and Wilcoxon’s nonparametric
tests using GraphPad Prism 5 software. The differences
between group means for the antioxidant enzymes,
MDA and plasma lipids were made by one-way
ANOVA. Significance was established at the 95% confi-
dence level (P < 0.05).
Results
Establishment of canola-induced life shortening model
Canola oil ingestion significantly decreased the life span
of SHRSP rats (P < 0.001). Mean lifespan of the two diet
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groups was 98.3 ± 3.4 days in the soybean oil group
compared to 85.8 ± 1.1 days in the canola oil group
(Figure 1), confirming the establishment of the model.
Body weight, food intake and water intake
Body weight of the animals increased gradually until the
5th week of administration in both diet groups. There
was no significant difference between soybean oil and
canola oil groups (Figure 2). There was also no significant
difference in food consumption and water intake between
the soybean oil and canola oil groups (Figure 3).
Blood pressure
Mean systolic blood pressure increased over time in the
soybean oil and canola oil groups. At the 6th week of
administration the mean systolic blood pressure was sig-
nificantly higher in the canola oil group compared to
soybean oil, 230.7 ± 3.5 and 213.6 ± 3.3 mmHg, respec-
tively (P < 0.05, Figure 4).
Antioxidant enzymes and oxidative damage
Markers of antioxidant status and oxidative damage are
represented in Table 2. Canola oil ingestion significantly
reduced (P < 0.05) the activities of RBC SOD, GPx and
catalase compared to soybean oil. The activities of RBC
SOD and GPx were significantly lower (P < 0.05) in the
canola oil group compared to pre-treatment, however,
there were no significant differences between the soy-
bean oil group and pre-treatment.
Canola oil ingestion significantly decreased (P < 0.05)
plasma MDA and 8-isoprostane in SHRSP rats com-
pared to the soybean oil group. Nevertheless, plasma 8-
isoprostane in the soybean oil group and MDA in both
canola oil and soybean oil groups was significantly
higher (P < 0.05) than the pre-treatment group. Lastly,
RBC MDA in the soybean oil group was significantly
lower (P < 0.05) than pre-treatment.
Plasma lipids
Canola oil ingestion significantly reduced (P < 0.05) the
concentration of total cholesterol and LDL-C compared
with soybean oil. Total cholesterol and LDL-C were
significantly lower (P < 0.05) in the canola oil group
compared with pre-treatment, however, there were no
significant differences between the soybean oil group
and pre-treatment. HDL-C in both canola oil and soy-
bean oil groups was significantly lower (P < 0.05) than
pre-treatment. There were no significant differences
(P > 0.05) in the concentration of triglycerides between
groups (Table 3).
Discussion
Previous studies have shown that the life span of SHRSP
rats is shortened when canola oil is the only dietary fat




















Figure 1 Survival curves of SHRSP rats fed a diet containing
10% soybean oil or canola oil. The curves are significantly
different (P < 0.001, Log-rank and Wilcoxon’s test). At the
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Figure 2 Mean body weight of SHRSP rats fed canola oil
compared with soybean oil diet. Vaules are means ± SEM. At the
commencement of the study the number of animals in each group
was 12. The numbers on the graph repesent the n in each group.
*P < 0.05 represents a significant difference between canola and
soybean oil groups.
*
Figure 3 Food and water intake of SHRSP rats fed canola oil
compared with soybean oil diet. Values are means ± SEM. At the
commencement of the study the number of animals in each group
was 12. The numbers on the graph repesent the n in each group.
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source [1,2,5-8] which is confirmed by the present study,
which showed shortened life span of approximately 13%
with canola oil feeding compared with soybean oil
under 1% NaCl loading. Our results are similar to the
study published by Ratnayake et al. (2000b) [9], which
produced a 13% reduction in life span with canola oil
feeding. Canola oil has been reported to shorten the life
span of SHRSP rats compared with soybean oil, 254 ±
12 and 416 ± 16 days, respectively, even without NaCl
loading [1].
Evidence indicates that canola oil intake has an effect
on blood pressure in the SHRSP rat and its related
strains. However, blood pressure in the present study is
not a key contributing factor to the shortened life span,
as there was only one time difference between soybean
oil and canola oil. The results of the present study show
an increase in systolic blood pressure over time in both
treatment groups, with a difference between the groups
at the 6th week of administration. A study by Huang et
al. (1996) observed no significant change in systolic
blood pressure in the canola oil group compared to the
soybean oil group at 4 and 8 weeks of age [5]. Another
study by Ratnayake et al. (2000a) found no significant
differences in the SBP among different dietary groups in
SHRSP rats [8]. While previous literature has shown
that decreased antioxidants and oxidative stress play a
role in hypertension, to our knowledge this is the first
study to investigate the effect of canola oil on measures
of antioxidant status and oxidative damage in SHRSP
rats. In the present study canola oil ingestion decreased
the activities of SOD, GPx and catalase compared with
the soybean oil group by 25%, 18% and 31%, respec-
tively. Previous studies have analysed several antioxidant
enzymes in SHR and WKY rats. In the SHR, the activity
of RBC GPx and the activities of SOD and catalase in
the hepatic cytosol were found to be reduced [25]. In
WKY rats, canola oil ingestion increased the activity of
SOD and reduced the activity of catalase in the hepatic
cytosol [26], while an earlier study showed reduced
activities of SOD and catalase in the hepatic cytosol of
WKY rats [27]. Our data are largely consistent with
these findings. Taken together these results indicate that
canola oil ingestion affects antioxidant enzyme activity
in different tissues. Indeed, previous research has shown
an inverse relationship between erythrocyte GPx activity
and the incidence of cardiovascular disease [28]. Given
the physiological significance of the decreased erythro-
cyte GPx activity, further research is required to deter-
mine the mechanism to explain the canola-oil induced
changes to antioxidant enzyme activity.
In the present study, canola oil ingestion decreased
the plasma 8-isoprostane and MDA concentration when
Table 2 Antioxidant status and oxidative damage in
SHRSP rats fed canola oil compared with soybean oil
diets
Pre-treatment Post-treatment
Soybean oil Canola oil
RBC SOD (U/gm Hb) 1608.7 ± 121.8 1454 ± 111.3 1087.2 ± 92.9*, #
RBC GPx (U/gm Hb) 523.0 ± 25.9 512 ± 36.6 415 ± 19.4*, #
RBC Catalase
(mmol/min/gm Hb)
155.6 ± 13.4 208.2 ± 35.1 142.4 ± 15.9*
RBC MDA (μM) 28.6 ± 1.6 16.6 ± 3.5# 21.8 ± 3.9
Plasma MDA (μM) 11.8 ± 0.5 17.9 ± 0.5# 14.9 ± 1.3*, #
Plasma 8-isoprostane
(pg/ml)
75.2 ± 12.3 103.2 ± 7.6# 83.2 ± 5.6*
Values are means ± SEM; Number of animals at post-treatment was 10.
Number of animals in each group at post-treatment for soybean oil and
canola oil was 9 and 8, respectively. SOD, superoxide dismutase; GPx,
glutathione peroxidase; MDA, malondialdehyde.
*P < 0.05 represents a significant difference between canola and soybean oil
groups.
#P < 0.05 represents a significant difference between pre-treatment vs post-
treatment.
Table 3 Plasma lipids in SHRSP rats fed canola oil




Soybean oil Canola oil
Total cholesterol 7.9 ± 0.2 7.9 ± 0.4 6.67 ± 0.3*, #
LDL-C 5.3 ± 0.2 5.6 ± 0.4 4.57 ± 0.2*, #
HDL-C 2.4 ± 0.1 1.8 ± 0.1# 1.67 ± 0.1#
Triglycerides 1.4 ± 0.1 1.4 ± 0.1 1.21 ± 0.1
Values are means ± SEM; Number of animals at post-treatment was 10.
Number of animals in each group at post-treatment for soybean oil and
canola oil was 9 and 8, respectively. SOD, superoxide dismutase; GPx,
glutathione peroxidase; MDA, malondialdehyde.
*P < 0.05 represents a significant difference between canola and soybean oil
groups.
#P < 0.05 represents a significant difference between pre-treatment vs
post-treatment.
*
Figure 4 Mean systolic blood pressure of SHRSP rats fed
canola oil compared with soybean oil diets. Vaules are means ±
SEM. At the commencement of the study the number of animals in
each group was 12. *P < 0.05 represents a significant difference
between canola and soybean oil groups.
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compared to the soybean oil group. These results are
unexpected given the canola oil-induced decrease in ery-
throcyte antioxidant enzyme activity. The mechanism to
explain the decreased plasma 8-isoprostane and MDA
concentration despite a decrease in RBC antioxidant
enzyme activity is currently unknown. Plasma 8-isopros-
tane in the soybean oil and MDA in both the canola oil
and soybean oil groups was higher than the pre-treat-
ment group. In a previous study in WKY rats, canola oil
ingestion increased lipid peroxide levels in the hepatic
cytosol [26], while an earlier study showed no change in
lipid peroxide levels in the hepatic cytosol of SHR [25].
The increased plasma 8-isoprostane in the soybean oil
group and MDA concentrations in both dietary groups
compared to pre-treatment indicates an increased
amount of ROS induced lipid peroxidation over time
independent from the consumption of either canola or
soybean oil. RBC MDA was decreased in the soybean oil
group compared to pre-treatment, and indicates a
decrease in erythrocyte lipid peroxidation over time.
Previous investigations that have determined the poten-
tial for cellular membranes to undergo oxidation based
on their fatty acid composition [29] suggest that the
change in lipid peroxidation observed in the present
study is in contrast to what may be expected based on
the fatty acid composition of canola and soybean oil.
Canola oil has relatively more n-9 monousnsatruated
fatty acids, more readily oxidised, compared to soil bean
oil that has proportionally more n-6 polyunsaturated
fatty acids, less readily oxidised [4]. However only focus-
ing on the fatty acid composition alone of the two oils
is too simplistic as the TAS for both diets was the same
and the lower concentration of RBC MDA in the soy-
bean oil group may have resulted from the higher RBC
antioxidant activities compared to the canola oil group.
Whichever the case the specific mechanism for these
differences in RBC lipid peroxidation associated with the
consumption of canola or soybean oil was not identified
in the present study. Therefore, more research is clearly
required to investigate the effect of canola oil intake on
oxidative damage in SHRSP rats.
Canola oil ingestion reduced the concentration of total
cholesterol and LDL-C compared with soybean oil and
the pre-treatment group. HDL-C was lower in both diet-
ary groups compared with pre-treatment, and there
were no changes found in the triglyceride levels between
the groups. However, previous studies in SHR and WKY
rats have shown increases in total cholesterol, triglycer-
ides and HDL-C with administration of canola oil com-
pared to soybean oil [25-27]. A study by Ohara et al.
(2006) found no changes in the plasma lipids in the
canola oil group after an eight week feeding trial in
SHRSP rats [7]. Canola oil is considered to provide pro-
tective cardiovascular effects due to its favourable fatty
acid composition [8]. Canola oil has a high content of
oleic acid (55-60%), a low content of saturated fatty
acids (6-7%), and provides a good source of omega-3
fats [4]. The present study supports the beneficial health
effects of canola oil, as the plasma lipids were reduced
in SHRSP rats. A Previous study has shown that a
canola oil rich diet reduced plasma cholesterol, LDL-C
and HDL-C concentrations in middle-aged and elderly
hypercholesterolemic subjects [30]. Canola oil has also
been shown to reduce total plasma cholesterol and
LDL-C in the young men [31]. Whilst this present study
supports the beneficial health effects of canola oil on
blood lipids, it should also be pointed out that the meta-
bolism of cholesterol in rats is different from cholesterol
metabolism in humans [32]. Therefore direct extrapola-
tion of our circulating cholesterol results into humans
must be done so with caution. However, the effects of
canola oil ingestion in the SHRSP rat is still detrimental
as this oil leads to a shorten life span in SHRSP rats.
There are a number of limitations associated with the
present study in addition to the differences between
cholesterol metabolism in rats and humans. The first is
the question of whether the life shortening effect asso-
ciated with canola oil consumption is specific to rats
originally derived from the normotensive Wistar Kyoto
(WKY) strain. When canola oil was the only dietary fat
fed to WKY rats, a significant increase in systolic blood
pressure after five weeks of canola oil feeding was
observed and persisted until the conclusion of the trial
at week 13, compared to soybean oil fed rats [27]. In
addition when spontaneously hypertensive rats (SHR)
rats were fed canola oil canola they developed vascular
lesions in the kidney, had elevated plasma lipids and
glucose-6-phosphate dehydrogenase (G6PD) activation
in the liver and erythrocytes compared to SHR fed soy
oil [25]. In human populations there is only one pub-
lished incidence of canola oil being associated with the
development of disease [33] and this due was to manu-
facturing error when producing canola oil. The present
study did not directly investigate the effect of canola oil
on cell membrane fatty acid composition, fluidity, anti-
oxidant capacity or oxidized membrane lipids. Although
MDA was measured in plasma and lysed red blood
cells, the membrane fraction of red blood cells or other
organs was not isolated prior to measurement of MDA.
A change to cell membrane composition has previously
been investigated as a potential mechanism to explain
the life shortening effects of canola oil in the SHRSP.
These previous studies suggested that hyperabsorption
and accumulation of plant sterols found in canola oil
altered the fluidity of the membranes present in red
blood cells, liver and kidney and contribute to the life
shortening effect observed in SHRSP rats [9]. Finally
NaCl loading is used to accelerate the development of
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hypertension in the SHRSP [1,2,5-8], however it may be
masking the effects of canola oil in the SHRSP rat, and
thus further investigation on the life shortening effect of
canola oil in the absence of NaCl are required.
In conclusion, we have shown that canola oil ingestion
mediated life span shortening of SHRSP rats leads to
changes in oxidative status. The plasma lipids were
reduced after canola oil ingestion highlighting the health
benefits of canola oil intake. Despite the improvement
in the plasma lipids, canola oil was detrimental to the
SHRSP rat as their life span is reduced. Further research
is required to determine whether oxidative stress plays a
role in SHRSP rats due to canola oil ingestion.
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